Schall Brown & Schwartz LLP said investors who bought Embecta Corp. securities during the November 25, 2025 to May 4, 2026 class period may be eligible to seek compensation in a securities class action, with a lead plaintiff deadline of August 17, 2026. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 through allegedly false and misleading statements about the company’s basis for its second-quarter and full-year 2026 fiscal guidance. The firm said the case centers on allegations that Embecta knew headwinds in certain markets, including the pen needle market, were likely to affect performance against that guidance, and that investors were harmed when the market learned the alleged truth. The release also states that lead plaintiff status is not required to share in any potential recovery and that the class has not yet been certified.